Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression.
Neoplasma
; 69(6): 1253-1269, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35951454
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteopontin
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Neoplasma
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Eslovaquia